CVS Health Corp (CVS) posted earnings results for the third quarter of 2018 on Tuesday, November 6, before the opening bell. Net revenues improved 2.4% to $47.3 billion, while GAAP diluted EPS from continuing operations was $1.36. Adjusted earnings was $1.73 a share.
The Street had expected earnings of $1.71 per share on revenues of $47.1 billion, which the company beat. Shares jumped 2.59% in premarket trade from Monday’s close of $73.69 after the earnings announcement.
With this result, CVS Health has consistently topped estimates for five quarters in a row.
Same-store sales increased 6.7% and pharmacy same-store sales increased 8.7% in the three months ended September 30, 2018. Same-store prescription volume improved 9.2%, while Pharmacy Services claims grew of 5.7%.
Net income for the period rose 8.2% to $1.4 billion.
CVS Health continues to expect full-year GAAP consolidated operating profit to decline 39-41%, due to the goodwill impairment in Q2. Adjusted consolidated operating profit is expected to be down 0.75% to up 0.75% for the full year. The company continues to expect GAAP diluted earnings of $1.40-1.50 per share and adjusted earnings of $6.98-7.08 a share. Cash flow from operations is touted to hit $9.0 billion, with free cash flow of about $7.0 billion.
Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a
PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the
With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,